NewsBenzingaWhy Is First Tracks Biotherapeutics Stock Soaring Monday? Why Is First Tracks Biotherapeutics Stock Soaring Monday? Benzinga 2026.10.12 12:23 (GMT+0) Open on Benzinga Other news Barclays Maintains Equal-Weight on Exelon, Lowers Price Target to $44 The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition. Citizens Financial Analysts Slash Their Forecasts Following Q3 Results Barclays Maintains Overweight on Evergy, Lowers Price Target to $86 Barclays Maintains Overweight on Entergy, Lowers Price Target to $115 ‘CoreWeave Is the Canary in the Coal Mine’: Expert Warns More AI Debt Will Slide into Distress
The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition.
